NCT03387111 2024-08-05QUILT-3.090: NANT Squamous Cell Carcinoma (SCC) Vaccine: Subjects With SCC Who Have ProgressedImmunityBio, Inc.Phase 1/2 Terminated4 enrolled 14 charts
NCT01763788 2019-10-25A Study of Necitumumab in the First-Line Treatment of Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC)Eli Lilly and CompanyPhase 1/2 Completed192 enrolled 24 charts